Figure Legends.
Figure 1: Flowchart of patients included in the study.
Figure 2: A. Cumulative survival free of VT recurrence stratified by baseline inducibility over 66 months; B. Cumulative survival free of VT recurrence stratified by activation mapping during VT ablation procedure over 66 months.
Figure 3: A. Cumulative survival free of death/cardiac transplantation stratified by baseline inducibility + VT activation mapping over 66 months; B. Cumulative survival free of death/cardiac transplantation stratified by VT recurrence over 66 months.
Figure 4. Principal outcomes per study group (%).